1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Pooled subgroup analysis and metaregression for CTP for detection of delayed cerebral ischemia
Studies Pooled Sensitivity (%) Pooled Specificity (%) Positive LR Negative LR Diagnostic OR (95% CI) (95% CI) CTP <72 hr 5 55.8 (27.3–80.8) 93.7 (66.8–99.1) 8.81 (1.12–68.38) 0.47 (0.23–0.96) 18.0.66 (1.45–239.63) CTP >72 hr 5 84.5 (57.3–95.7) 84.9 (48.0–97.2) 5.60 (1.14–27.60) 0.18 (0.05–0.65) 30.73 (2.50–378.08) Relative sensitivity >72 hr vs <72 hr = 1.52 (95% CI, 0.85–2.68); P = .11; relative specificity >72 hr vs <72 hr = 0.91 (95% CI, 0.67–1.22); P = .47 MTT threshold 5 75.4 (61.6–85.4) 66.6 (51.3–79.0) 2.25 (1.33–3.81) 0.37 (0.20–0.69) 6.10 (1.98–18.78) MTT qualitative 5 67.9 (56.9–85.9) 78.8 (69.2–85.9) 3.19 (2.09–4.89) 0.41 (0.29–0.57) 7.86 (3.92–15.76) Relative sensitivity threshold vs qualitative = 1.14 (95% CI, 0.92–1.40); P = .24; relative specificity threshold vs qualitative = 0.82 (95% CI, 0.66–1.02); P = .10 CBF 7 74.1 (60.8–84.1) 87.4 (75.1–94.2) 5.91 (2.99–11.67) 0.30 (0.20–0.45) 19.96 (8.99–44.32) CBV 7 64.3 (50.6–75.9) 73.9 (60.1–84.1) 2.45 (1.72–3.52) 0.48 (0.37–0.64) 5.08 (3.16–8.17) Relative sensitivity CBV vs CBF = 0.88 (95% CI, 0.69–1.12); P = .30; relative specificity CBV vs CBF = 0.86 (95% CI, 0.70–1.05); P = .13 CBF 8 78.9 (72.7–84.0) 79.6 (64.7–89.3) 3.87 (2.11–7.10) 0.27 (0.19–0.36) 14.62 (6.38–33.49) MTT 8 81.5 (73.5–87.5) 79.2 (69.9–86.2) 3.91 (2.68–5.71) 0.23 (0.16–0.34) 16.77 (9.31–30.22) Relative sensitivity MTT vs CBF =1.03 (95% CI, 0.93–1.14); P = .64; relative specificity MTT vs CBF = 1.02 (0.85–1.23); P = .85 CBV 6 70.6 (63.0–77.2) 68.5 (59.9–75.9) 2.24 (1.72–2.91) 0.43 (0.33–0.56) 5.21 (3.24–8.40) MTT 6 84.3 (76.9–89.7) 74.4 (66.7–80.9) 3.30 (2.43–4.47) 0.21 (0.14–0.33) 15.64 (8.03–30.46) Relative sensitivity MTT vs CBV = 1.182 (95% CI, 1.05–1.33); P = .009; relative specificity MTT vs CBV = 1.09 (95% CI, 0.94–1.25); P = .27